Revolution Medicines Inc (RVMD)
103.24
-1.52%
Revolution Medicines Inc (RVMD) is currently trading at $103.24. This represents a loss of 1.52% from the previous session. With a market capitalization of $19.96B, RVMD is a key component of the Health Care sector. Investors looking to trade RVMD should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade RVMD commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Revolution Medicines Inc (RVMD) shows a bearish trend. Analysts are watching the 107.45 level closely.
Fundamentals
Mkt Cap19.96B
P/E Ratio0.0000
Volume2,823,170
60-Day Technical Chart
Advanced Charting
Need more indicators for RVMD? Use the world's #1 platform.
Open RVMD on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $103
| Metric |
RVMD -1.52% |
CRWV -1.30% |
NOW +1.70% |
TRI +10.31% |
|---|---|---|---|---|
| Price | $103.24 | $98.01 | $104.23 | $99.38 |
| Mkt Cap | $19.96B | $51.09B | $109.02B | $44.23B |
| - | View → | View → | View → |
Latest Headlines
Revolution Medicines, Inc. $RVMD Shares Sold by JPMorgan Chase & Co.
MarketBeat • Feb 23, 2026
Revolution Medicines to Report Financial Results for Fourth
GlobeNewswire • Feb 18, 2026
48,000 RAS G12V cancer cases a year as Revolution Medicines trials new drug
Stock Titan • Jan 29, 2026
Is It Too Late To Consider Revolution Medicines (RVMD) After Its Recent 50% Weekly Surge?
Yahoo Finance • Jan 10, 2026
RVMD Stock Hits a Record High on Rumored Takeover Interest
Zacks Investment Research • Jan 8, 2026
● Gemini Agentic AI Analyst Insight for RVMD
Market Education
- Canadian ETF Uptrend Pivot Dec 10, 2023
- Exploring Gann Trading: An Insightful Guide for Traders Jun 2, 2024
- Fails to Deliver DeMystified May 31, 2024
External Research